###begin article-title 0
###xml 99 104 <span type="species:ncbi:9606">Human</span>
Positive Selection and Increased Antiviral Activity Associated with the PARP-Containing Isoform of Human Zinc-Finger Antiviral Protein
###end article-title 0
###begin p 1
###xml 308 343 308 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Zinc-finger antiviral protein (ZAP)</italic>
###xml 592 595 592 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 732 735 732 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 926 929 926 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 1021 1024 1021 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 1261 1264 1261 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 349 353 <span type="species:ncbi:10116">rats</span>
###xml 420 441 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 920 925 <span type="species:ncbi:9606">human</span>
###xml 1017 1020 <span type="species:ncbi:10116">rat</span>
###xml 1160 1181 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 1197 1217 <span type="species:ncbi:11033">Semliki forest virus</span>
###xml 1255 1260 <span type="species:ncbi:9606">human</span>
Intrinsic immunity relies on specific recognition of viral epitopes to mount a cell-autonomous defense against viral infections. Viral recognition determinants in intrinsic immunity genes are expected to evolve rapidly as host genes adapt to changing viruses, resulting in a signature of adaptive evolution. Zinc-finger antiviral protein (ZAP) from rats was discovered to be an intrinsic immunity gene that can restrict murine leukemia virus, and certain alphaviruses and filoviruses. Here, we used an approach combining molecular evolution and cellular infectivity assays to address whether ZAP also acts as a restriction factor in primates, and to pinpoint which protein domains may directly interact with the virus. We find that ZAP has evolved under positive selection throughout primate evolution. Recurrent positive selection is only found in the poly(ADP-ribose) polymerase (PARP)-like domain present in a longer human ZAP isoform. This PARP-like domain was not present in the previously identified and tested rat ZAP gene. Using infectivity assays, we found that the longer isoform of ZAP that contains the PARP-like domain is a stronger suppressor of murine leukemia virus expression and Semliki forest virus infection. Our study thus finds that human ZAP encodes a potent antiviral activity against alphaviruses. The striking congruence between our evolutionary predictions and cellular infectivity assays strongly validates such a combined approach to study intrinsic immunity genes.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 668 672 <span type="species:ncbi:10116">rats</span>
###xml 1034 1039 <span type="species:ncbi:9606">human</span>
Host-virus interactions are a classic example of genetic conflict in which both entities try to gain an evolutionary advantage over the other. This "back-and-forth" evolution is predicted to result in rapid changes of both host and viral proteins, which results in an evolutionary signature of positive selection, especially at the direct interaction interface. Recent studies have demonstrated that host proteins can target intracellular stages of the viral life cycle to potently inhibit viruses. Collectively, these host proteins are referred to as "intrinsic immunity" proteins. One such protein, zinc-finger antiviral protein (ZAP), was previously described from rats and shown to inhibit retroviruses and alphaviruses. We queried the primate orthologs of ZAP to ascertain both whether they have evolved under positive selection, and whether they have antiviral activity. We found that the signature of positive selection was restricted to a poly(ADP-ribose) polymerase-like domain in a longer isoform of primate ZAP. The longer human ZAP isoform has increased antiviral activity against both retroviruses and alphaviruses. Thus, positive selection correctly predicted the more potent antiviral isoform of this protein.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b001">1</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b003">3</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b004">4</xref>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b006">6</xref>
###xml 1115 1116 1115 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b007">7</xref>
Recent discoveries have highlighted the role of intrinsic immunity genes in primate host defense against viral infections [1-3]. These genes are predicted to be locked in ancient, ongoing genetic conflicts with an ever-changing repertoire of viral infections [4-6]. Consistent with this prediction, the primate genes that encode for intrinsic immunity have been found to be evolving under positive selection, wherein they accumulate an excess number of non-synonymous substitutions (protein-altering, dN) compared to synonymous substitutions (no effect on protein, dS). This kind of selective pressure is seen in cases where innovation in protein sequence can result in a selective advantage and rapid fixation, as is the case for a host immunity gene where a single mutation might improve its ability to recognize and destroy a pathogen. In fact, genome-wide scans for positively selected genes in primates reveal that adaptively evolving genes fall primarily into three functional categories: immune defense, chemosensory perception, and reproduction, with the majority of these genes being involved in immunity [7].
###end p 6
###begin p 7
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOBEC3G</italic>
###xml 115 122 115 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOBEC3</italic>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b008">8</xref>
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b009">9</xref>
###xml 202 205 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fv1</italic>
###xml 227 230 227 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus</italic>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b010">10</xref>
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b004">4</xref>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b006">6</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b010">10</xref>
###xml 604 605 604 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b004">4</xref>
Four known groups of intrinsic immunity genes have been preserved over a broad taxonomic range; APOBEC3G and other APOBEC3 genes as well as TRIM5 are conserved across many mammalian orders [8,9], while Fv1 is conserved in many Mus species [10]. All three of these groups of these intrinsic immunity genes have been shown to evolve under positive selection [4-6,10]. A signature of positive selection has not only provided information about the antiviral activity and age of these "restriction" genes, but has also helped to identify protein domains at the direct interface of the host-virus interaction [4].
###end p 7
###begin p 8
###xml 87 127 87 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zinc-finger antiviral protein (ZAP). ZAP</italic>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rZAP</italic>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b011">11</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b012">12</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b013">13</xref>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b014">14</xref>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b015">15</xref>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b016">16</xref>
###xml 869 872 869 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 133 136 <span type="species:ncbi:10116">rat</span>
###xml 246 251 <span type="species:ncbi:10090">mouse</span>
###xml 264 285 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 287 290 <span type="species:ncbi:11786">MLV</span>
###xml 944 950 <span type="species:ncbi:9606">humans</span>
The fourth intrinsic immunity gene that is present over a broad taxonomic range is the zinc-finger antiviral protein (ZAP). ZAP from rat cells (referred to as rZAP) was identified due to its ability to significantly impair the replication of the mouse retrovirus, murine leukemia virus (MLV), through a mechanism that involves binding and degrading viral RNAs in the cytoplasm [11]. Viral RNA recognition by rZAP is mediated by the 4 CCCH zinc finger motifs, which have been shown to directly bind viral RNA with high specificity [12]. ZAP-dependent recruitment of an RNA processing exosome in the cytoplasm then leads to viral RNA degradation [13]. Subsequent studies have found that rZAP can inhibit both alphaviruses [14,15] and filoviruses [16] by inhibiting the translation of incoming viral RNA. We undertook a combined approach using an evolutionary analysis of ZAP orthologs in primates as well as functional tests of ZAP isoforms from humans.
###end p 8
###begin p 9
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 206 212 206 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 227 234 227 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(S).</italic>
###xml 251 254 251 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b011">11</xref>
###xml 483 486 483 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 688 691 688 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 793 796 793 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 864 867 864 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 247 250 <span type="species:ncbi:10116">rat</span>
###xml 317 322 <span type="species:ncbi:9606">human</span>
###xml 397 400 <span type="species:ncbi:10116">rat</span>
###xml 1057 1062 <span type="species:ncbi:9606">human</span>
###xml 1123 1126 <span type="species:ncbi:11786">MLV</span>
###xml 1190 1193 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
###xml 1199 1204 <span type="species:ncbi:9606">human</span>
###xml 1286 1291 <span type="species:ncbi:9606">human</span>
The human ortholog of the ZAP gene encodes 2 protein isoforms that result from alternative splicing of a carboxy-terminal poly(ADP-ribose) polymerase (PARP)-like domain. This PARP-like domain is present in ZAP(L) and absent in ZAP(S). Two shorter rat ZAP isoforms have previously been described, one corresponding to human ZAP(S) and the other to just the first 254 amino acids of the N-terminus (rat NZAP), and neither contain the PARP-like domain[11]. Our evolutionary analysis of ZAP revealed strong evidence of positive selection throughout primate evolution. By examining the pattern of evolutionary change in this gene, we found, surprisingly, no evidence for positive selection in ZAP's CCCH RNA-binding domain. This implies that rapid alterations of viral mRNA binding have not driven ZAP evolution. Instead, the signature of positive selection in primate ZAP is confined to the PARP-like domain, implicating this domain as an uncharacterized and evolutionarily important interface for ZAP-virus interactions. Using infectivity assays, we show that human ZAP is capable of restricting expression of the retrovirus, MLV, as well as infection by the alphavirus, Semliki Forest virus (SFV), in human cells. Moreover, we show that the presence of the PARP-like domain in the longer human ZAP isoform significantly enhances this restrictive capability against both viruses, making this the first demonstration of a PARP-like domain being implicated in an immunity role. Our results demonstrate that a combination of evolutionary and virological analyses can identify and validate specific protein domains involved in host-pathogen interactions, thereby uncovering previously unknown antiviral activity.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
Two Predominant ZAP Isoforms
###end title 11
###begin p 12
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 68 76 68 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g001">Figure 1</xref>
###xml 137 140 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 304 310 304 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(S)</italic>
###xml 315 322 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L),</italic>
###xml 337 345 337 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g001">Figure 1</xref>
###xml 353 359 353 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b017">17</xref>
###xml 732 736 732 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rZAP</italic>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b011">11</xref>
###xml 877 885 877 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g001">Figure 1</xref>
###xml 932 936 932 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rZAP</italic>
###xml 1068 1074 1068 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(S)</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 776 779 <span type="species:ncbi:10116">rat</span>
###xml 793 796 <span type="species:ncbi:10116">rat</span>
###xml 992 995 <span type="species:ncbi:10116">rat</span>
###xml 1062 1067 <span type="species:ncbi:9606">human</span>
The human ZAP gene comprises 13 exons spanning approximately 60 kb (Figure 1A). The two reported alternatively spliced isoforms of human ZAP code for proteins that either lack or contain a carboxy-terminal PARP-like domain (Refseq NM_020119.3 and NM_024625.3). We refer to the short and long isoforms as ZAP(S) and ZAP(L), respectively (Figure 1A). The ZAP(L) isoform encodes a protein with an N-terminal CCCH domain (four CCCH motifs), a TPH, or TiPARP Homology domain (conserved among ZAP paralogs and containing a fifth zinc finger motif), a WWE domain (predicted to mediate specific protein-protein interactions in ubiquitin and ADP-ribose conjugation proteins [17]) and a C-terminal PARP-like domain. The antiviral activity of rZAP was first discovered using a truncated rat ZAP protein (rat NZAP), which consisted only of the 4 CCCH motifs that mediate RNA binding [11] (Figure 1A). Subsequent analyses revealed that a longer rZAP protein also has antiviral ability. However, even this rat ZAP, presumed at the time to be "full length," corresponds to the human ZAP(S) isoform and does not include the C-terminal PARP domain.
###end p 12
###begin title 13
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(S)</italic>
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
ZAP(S) and ZAP(L) Isoforms in Mammals
###end title 13
###begin p 14
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 495 501 495 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 591 597 591 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 850 853 850 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 440 445 <span type="species:ncbi:9606">human</span>
###xml 521 524 <span type="species:ncbi:10116">rat</span>
###xml 639 642 <span type="species:ncbi:10116">rat</span>
###xml 846 849 <span type="species:ncbi:10116">rat</span>
(A) Schematic of the genomic structure of human ZAP(L) and the protein structure with previously defined domains (CCCH fingers, TPH, WWE, and PARP-like). The asterisk indicates the stop codon for an alternative transcript that has been reportedly isolated from multiple cDNA libraries. An additional transcript with an alternatively spliced exon (366 bp) inserted after exon 4 was also identified in several primates (not shown) but not in human, so our evolutionary analysis was limited to the ZAP(L) isoform shown. The rat NZAP (254 aa) protein structure is shown for comparison. A longer ZAP(L) isoform was also detected by RT-PCR from rat liver RNA using a forward primer in the WWE domain (exon 7) and a reverse primer in the PARP domain (exon 13) (see arrows). The resulting product was directly sequenced and corresponded to exons 7-13 of rat ZAP (gel inset).
###end p 14
###begin p 15
###xml 239 245 239 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(S)</italic>
###xml 250 253 250 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(L)</italic>
###xml 4 9 <span type="species:ncbi:9606">Human</span>
###xml 171 176 <span type="species:ncbi:9606">human</span>
###xml 233 238 <span type="species:ncbi:9606">human</span>
(B) Human ZAP isoforms are expressed in a wide range of tissues, including germline tissues and peripheral blood lymphocytes (PBLs). Results from PCR amplification from a human multiple tissue cDNA panel with primers specific to the human ZAP(S) and (L) isoforms (top and bottom panels, respectively). Lanes are labeled according to the template tissue (M, DNA standard marker; blank, no template).
###end p 15
###begin p 16
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(S)</italic>
###xml 167 173 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 184 192 184 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g001">Figure 1</xref>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(S)</italic>
###xml 279 285 279 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 308 314 308 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 496 502 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 532 539 532 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOBEC3</italic>
###xml 606 607 606 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b006">6</xref>
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 104 109 <span type="species:ncbi:9606">human</span>
To gauge the tissue-specificity of the two human isoforms relative to each other, we used RT-PCR from a human tissue cDNA panel and primers specific to the ZAP(S) and ZAP(L) isoforms (Figure 1B). We found that ZAP(S) is expressed has a broader expression pattern compared to the ZAP(L) isoform. However, the ZAP(L) isoform is expressed in tissues where it may mediate an intrinsic immunity function, including germline tissues and peripheral blood lymphocytes (PBLs). Indeed, the tissue range of ZAP(L) is comparable to some of the APOBEC3 genes that we have analyzed previously using the same cDNA panel [6].
###end p 16
###begin p 17
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 176 182 176 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(S)</italic>
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 403 409 403 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 491 494 491 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 606 612 606 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(S)</italic>
###xml 617 623 617 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 685 688 685 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 707 713 707 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 762 770 762 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g001">Figure 1</xref>
###xml 925 931 925 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 966 972 966 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(S)</italic>
###xml 1011 1019 1011 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g001">Figure 1</xref>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 115 118 <span type="species:ncbi:10116">rat</span>
###xml 170 175 <span type="species:ncbi:9606">human</span>
###xml 235 238 <span type="species:ncbi:10116">rat</span>
###xml 243 248 <span type="species:ncbi:10090">mouse</span>
###xml 536 539 <span type="species:ncbi:10116">rat</span>
###xml 681 684 <span type="species:ncbi:10116">rat</span>
###xml 1003 1009 <span type="species:ncbi:9606">humans</span>
Next, we wanted to address whether ZAP(L) is limited to the primate lineage. The Refseq entries for both mouse and rat ZAP proteins only refer to a protein equivalent of human ZAP(S). On examining the genomic sequence context for both rat and mouse ZAP genes, we found that they both have a downstream set of exons that could encode a putative PARP domain that would be orthologous to that from primate ZAP(L). In order to determine whether these exons are spliced onto the remainder of the ZAP gene, we performed RT-PCR using RNA from rat liver and primers designed to the WWE domain (shared between both ZAP(S) and ZAP(L) isoforms) and the PARP domain. Indeed, we found that the rat ZAP gene can encode a ZAP(L) isoform that includes a C-terminal PARP domain (Figure 1A). The reason this isoform appears to have been missed until now is because no ESTs corresponding to this PARP domain have been reported, suggesting that ZAP(L) may be more weakly expressed than ZAP(S) in rodents, as is the case in humans (Figure 1B).
###end p 17
###begin p 18
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 117 132 117 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP11, PARP12,</italic>
###xml 137 143 137 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TiPARP</italic>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b018">18</xref>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZRP2</italic>
###xml 204 213 204 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0040021-sg001">Figure S1</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b019">19</xref>
###xml 325 332 <span type="species:ncbi:9031">chicken</span>
In terms of overall architecture and paralogous genes, ZAP is most closely related to 3 other PARP-containing genes: PARP11, PARP12, and TiPARP [18] as well as ZRP2, which only consists of a CCCH domain (Figure S1). Putative orthologs for all five genes can be found in genome sequences from a variety of mammals, as well as chicken and fish, suggesting that this gene family is ancient [19] and that the PARP-containing ZAP isoform dates back to the origin of vertebrates.
###end p 18
###begin title 19
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
Positive Selection of Primate ZAP
###end title 19
###begin p 20
###xml 116 122 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 477 485 477 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g002">Figure 2</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b020">20</xref>
###xml 716 724 716 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g002">Figure 2</xref>
###xml 776 779 776 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 951 954 951 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 1015 1016 1015 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1027 1034 1027 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0040021-t001">Table 1</xref>
###xml 1057 1060 1057 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
To investigate whether the ZAP gene has evolved under positive selection during primate evolution, we sequenced the ZAP(L) coding sequence (2.7 kb) via RT-PCR from 13 primates representing 33 million years of evolution. Our analysis included 6 hominoids, 3 Old World monkeys (OWM), and 4 New World monkeys (NWM). The phylogeny constructed from the primate ZAP sequences was congruent with the generally accepted primate phylogeny confirming that the sequences are orthologous (Figure 2A). Using the free-ratio model in the PAML suite of programs [20], which allows an independent assignment of dN/dS ratios to each evolutionary branch, we found that several branches of the phylogeny show dN/dS > 1 (bold numbers in Figure 2A). Furthermore, when we compared the likelihood of ZAP evolution under codon models that prohibit (Nsites models M1, M7, or M8a) or permit positive selection (M2 and M8), we found that models permitting positive selection fit ZAP evolution significantly better than those that disallow it (p < 0.0003, Table 1). This indicates that ZAP has evolved under positive selection during primate evolution, suggesting it has a long history of actively participating in host-pathogen interactions.
###end p 20
###begin title 21
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
Positive Selection of ZAP(L) in Primates
###end title 21
###begin p 22
###xml 84 90 84 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
(A) Ancient signature of positive selection in primate ZAP. A sequence alignment of ZAP(L) from four New World monkeys, three Old World monkeys, and six hominoids was analyzed using the free-ratio model from PAML, which allows dN/dS to vary along each branch. The corresponding dN/dS values are shown for each branch, and bold numbers indicate those branches with dN/dS > 1. In the case of no observed synonymous changes (inf), a dN/dS ratio could not be calculated.
###end p 22
###begin p 23
(B) An alignment of a segment of the PARP domains from these primate species is shown. Identical and similar residues are indicated with asterisks (*) and colons (:), respectively. The 3 residues identified with high confidence as evolving under positive selection are indicated with exclamation marks and lie in close proximity to the NAD+ binding contact residues (indicated by yellow boxes).
###end p 23
###begin p 24
Likelihood Ratio Test Statistics for Models of Variable Selective Pressure Among Sites
###end p 24
###begin p 25
###xml 524 533 524 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0040021-sg001">Figure S1</xref>
###xml 858 867 858 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0040021-sg002">Figure S2</xref>
###xml 1001 1008 1001 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0040021-t001">Table 1</xref>
To determine which domains were responsible for the signature of positive selection in ZAP, we performed three separate PAML analyses using the N-terminal CCCH domain (amino acids [aa] 1-240), the central domain containing the TPH and WWE motifs (aa 241-700), or the C-terminal PARP domain (aa 701-902). Significantly, our PAML analyses did not reveal any evidence for positive selection acting on the N-terminal CCCH domain. Indeed, we found a high degree of conservation of the CCCH domain throughout mammalian evolution (Figure S1), arguing that rapid alteration of viral RNA-binding has not had a significant impact on ZAP evolution. Sliding window dN/dS analyses based on different pairwise alignments of primate ZAP genes suggests that positive selection may have episodically acted on the central domain containing the TPH and WWE motifs (aa 241-700; Figure S2). However, since no codons show a recurrent signature of positive selection, these domains are not highlighted by the PAML analyses (Table 1).
###end p 25
###begin p 26
###xml 96 103 96 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0040021-t001">Table 1</xref>
###xml 273 274 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 521 528 521 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0040021-t001">Table 1</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b020">20</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b021">21</xref>
###xml 633 641 633 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g002">Figure 2</xref>
###xml 785 787 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b022">22</xref>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b023">23</xref>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b024">24</xref>
###xml 1336 1339 1336 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 1398 1402 1398 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rZAP</italic>
###xml 839 846 <span type="species:ncbi:9031">chicken</span>
Rather, we found a robust signature for positive selection in the PARP-like domain (aa 701-902; Table 1). We found that a model of episodic positive selection (Free Ratio) was significantly more likely than a model of constant positive selection (Model 0, one fixed dN/dS; p = .01, df = 21), suggesting that ZAP has been engaged in episodic conflicts with exogenous infectious agents. Three codons were identified as having evolved under recurrent positive selection in the PARP domain, using both PAML and REL analyses (Table 1) [20,21]. Surprisingly, the three residues for which we obtained high confidence of positive selection (Figure 2B) are found in close proximity to residues that are thought to mediate the contact residues for NAD+ binding (cd01439.2 from the CDD database [22] largely modeled from the crystal structure of the chicken PARP-1 catalytic domain [23,24]). This is highly unexpected because it would seem that these residues should be highly constrained as part of PARP or PARP-like function, for which NAD+ binding is obligatory. It is possible that these residues could be rapidly evolving because of ZAP(L) interactions with viral proteins that may involve the same protein domains that interact with NAD+. Thus, contrary to expectation, the only signature of recurrent positive selection we found in primate ZAP evolution is limited to a domain that is missing from the rZAP gene, which is the only version that has been previously tested in any antiviral assays. Since protein innovation has been primarily favored exclusively in the PARP domain, this would predict that ZAP(L) is the more evolutionarily relevant antiviral isoform. This prediction can be directly evaluated by testing whether the region under the most intense positive selection, the PARP-like domain, enhances the antiviral activity of ZAP.
###end p 26
###begin title 27
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human ZAP(L) Is a More Potent Viral Inhibitor than ZAP(S)
###end title 27
###begin p 28
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b011">11</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b012">12</xref>
###xml 682 683 682 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 795 803 795 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g003">Figure 3</xref>
###xml 947 955 947 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g003">Figure 3</xref>
###xml 957 958 957 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g003">3</xref>
###xml 1115 1123 1115 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g003">Figure 3</xref>
###xml 1680 1688 1680 1688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g003">Figure 3</xref>
###xml 1792 1794 1792 1794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b011">11</xref>
###xml 1829 1832 1829 1832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 1873 1879 1873 1879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 1915 1922 1915 1922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(S).</italic>
###xml 31 34 <span type="species:ncbi:10116">rat</span>
###xml 76 79 <span type="species:ncbi:11786">MLV</span>
###xml 94 97 <span type="species:ncbi:11786">MLV</span>
###xml 164 169 <span type="species:ncbi:9606">human</span>
###xml 252 255 <span type="species:ncbi:10116">rat</span>
###xml 379 382 <span type="species:ncbi:11786">MLV</span>
###xml 485 488 <span type="species:ncbi:11786">MLV</span>
###xml 500 503 <span type="species:ncbi:11786">MLV</span>
###xml 596 599 <span type="species:ncbi:11786">MLV</span>
###xml 636 639 <span type="species:ncbi:10116">rat</span>
###xml 757 760 <span type="species:ncbi:11786">MLV</span>
###xml 886 889 <span type="species:ncbi:11786">MLV</span>
###xml 1340 1343 <span type="species:ncbi:11786">MLV</span>
###xml 1547 1550 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1602 1607 <span type="species:ncbi:9606">human</span>
###xml 1627 1630 <span type="species:ncbi:10116">rat</span>
###xml 1653 1656 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1782 1785 <span type="species:ncbi:10116">rat</span>
###xml 1823 1828 <span type="species:ncbi:9606">human</span>
The original identification of rat NZAP was based on its ability to inhibit MLV infection and MLV long terminal repeat (LTR)-based expression. We created HA-tagged human ZAP(L) and ZAP(S) expression constructs in parallel with the previously described rat NZAP clone [11] and then tested their restrictive capabilities by co-transfecting increasing amounts of ZAP plasmid with a MLV-based vector, in which the firefly luciferase reporter gene is inserted between the 5' and 3' LTRs of MLV. A similar MLV-based luciferase reporter construct was previously used to show that the 3' LTR sequence of MLV is the target of the CCCH domain of rat NZAP [12]. In repeated luciferase assays (n = 6), we found that all ZAP expression plasmids significantly suppressed MLV LTR-driven luciferase expression (Figure 3A). Our experiments also show that ZAP(L) is a 2- to 3-fold stronger suppressor of MLV than ZAP(S) at the highest tested levels of ZAP (200 ng; Figure 3A-3B). In addition, Western analysis of lysates from the comparable transfections reveals that the ZAP(S) expression level is significantly higher than ZAP(L) (Figure 3C), despite equal amounts of transfected plasmid. This suggests a secondary control of ZAP(L) expression, which we have not explored further. However, these results do imply that the 2- to 3-fold higher inhibition of MLV expression seen with ZAP(L) is likely to be a significant underestimate. As a control, we also tested whether the ZAP isoforms were effective at inhibiting a similar construct that utilized the LTR from HIV to drive luciferase gene expression. We found that human ZAP(L), ZAP(S) and rat NZAP had no effect on HIV LTR-driven luciferase (Figure 3D), suggesting a strong specificity for retroviral inhibition, as was previously reported for rat NZAP [11]. These results demonstrate human ZAP has potent antiviral function, and that ZAP(L) is a more effective inhibitor than ZAP(S).
###end p 28
###begin title 29
###xml 36 39 <span type="species:ncbi:11786">MLV</span>
###xml 48 51 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
ZAP Viral Inhibition Is Specific to MLV but Not HIV, and the PARP Domain Enhances the Viral Restriction
###end title 29
###begin p 30
###xml 50 53 <span type="species:ncbi:11786">MLV</span>
###xml 71 74 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 160 163 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 169 172 <span type="species:ncbi:11786">MLV</span>
Co-transfections of ZAP isoforms with the LlucSN (MLV) or pwtLTR-luc1 (HIV) promoter constructs were used to assess the ability of the ZAP isoforms to restrict HIV- and MLV-driven luciferase.
###end p 30
###begin p 31
###xml 68 71 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 117 120 117 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 17 20 <span type="species:ncbi:11786">MLV</span>
###xml 175 178 <span type="species:ncbi:11786">MLV</span>
(A) ZAP inhibits MLV in cells transfected with equal amounts of the ZAP expression constructs. Equal amounts of each ZAP expression construct were co-transfected with LlucSN (MLV). All transfections were equalized for DNA amount with the addition of pcDNA. Lysates from transfected cells were collected after 24 h, and luciferase activity was measured.
###end p 31
###begin p 32
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(S)</italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 78 81 <span type="species:ncbi:11786">MLV</span>
(B) Effect of increasing amounts of transfected human ZAP(L) or ZAP(S) DNA on MLV-LTR driven luciferase expression. Lysates from transfected cells were harvested at 48 h, and luciferase activity was measured. Results are shown as percent luciferase expression of the control transfection (no ZAP). The results from one representative experiment are shown, with error bars reflecting the variation between triplicate infections within one experiment.
###end p 32
###begin p 33
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 145 155 145 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">luciferase</italic>
###xml 628 631 592 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 137 140 <span type="species:ncbi:11786">MLV</span>
###xml 341 344 <span type="species:ncbi:10116">rat</span>
(C) Equivalent amounts of lysates from 293T cells transiently co-transfected with different amounts of ZAP expression constructs and the MLV LTR-luciferase construct were analyzed by Western blot analysis to determine the relative amount of protein. Samples were harvested 48 hours after transfection. Sizes of HA-tagged ZAP(L), ZAP(S), and rat NZAP are approximately115 kDa, approximately80 kDa, and approximately30 kDa, respectively. Actin was the loading control. To determine the relative amounts of ZAP(L) and ZAP(S), Western blot analysis was performed on a dilution series of lysates from 293T cells transfected with the ZAP constructs.
###end p 33
###begin p 34
###xml 16 19 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 51 54 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 114 117 <span type="species:ncbi:10116">rat</span>
###xml 126 129 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 197 200 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 264 267 <span type="species:ncbi:11786">MLV</span>
(D) For ZAP and HIV co-transfections, pwtLTR-luc1 (HIV) was co-transfected with either no ZAP, ZAP(L), ZAP(S), or rat NZAP (a CMV-Tat construct was also transfected to improve expression levels of HIV). Transfections and luciferase assays were performed as in the MLV experiment.
###end p 34
###begin p 35
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b014">14</xref>
###xml 293 295 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b025">25</xref>
###xml 569 577 566 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g004">Figure 4</xref>
###xml 838 846 835 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g004">Figure 4</xref>
###xml 1347 1355 1344 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g004">Figure 4</xref>
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 185 188 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
###xml 241 244 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
###xml 391 396 <span type="species:ncbi:9606">human</span>
###xml 405 410 <span type="species:ncbi:9606">human</span>
###xml 422 425 <span type="species:ncbi:10116">rat</span>
###xml 504 507 <span type="species:ncbi:10116">rat</span>
###xml 606 609 <span type="species:ncbi:10116">rat</span>
###xml 658 661 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
###xml 769 772 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
###xml 828 831 <span type="species:ncbi:10116">rat</span>
###xml 894 899 <span type="species:ncbi:9606">human</span>
###xml 1105 1108 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1264 1267 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1391 1396 <span type="species:ncbi:9606">human</span>
###xml 1474 1477 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
Previous results have also demonstrated that rZAP can inhibit alphaviruses [14]. Therefore, we tested whether the two human ZAP isoforms were also capable of restricting an alphavirus, SFV, using a previously described DNA-based recombinant SFV vector system that expresses the beta-gal gene [25]. We performed single-round infectivity assays in HeLa cells lines stably-expressing HA-tagged human ZAP(L), human ZAP(S), or rat NZAP. The expression level of ZAP(L) was about equal to that of ZAP(S), while rat NZAP appeared to be more highly expressed in our cell lines (Figure 4A). While ZAP(L), ZAP(S) and rat NZAP all demonstrate antiviral activity against SFV infection, ZAP(L) was significantly more potent than the other isoforms, with almost 10-fold inhibition of SFV compared to only 2-fold inhibition by either ZAP(S) or rat NZAP (Figure 4B). To assess whether the antiviral activity of human ZAP is a general antiviral effect (and to rule out the possibility that our observations are due simply to greater cell death in ZAP(L)-expressing cells), we performed single-round infectivity assays with HIV expressing luciferase in HeLa cells stably expressing the ZAP isoforms. We found that none of the isoforms of ZAP were capable of significantly inhibiting HIV infection, demonstrating that the antiviral activity of ZAP is virus-specific (Figure 4C). Intriguingly, the expression of human ZAP isoforms in baby hamster kidney (BHK) cells did not confer resistance to SFV (unpublished data), suggesting that the rapid evolution of ZAP has likely resulted in species-specific restriction and that ZAP restriction of alphaviruses is at least partially dependent on the context of other host proteins.
###end p 35
###begin title 36
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 20 23 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
###xml 37 42 <span type="species:ncbi:9606">Human</span>
Human ZAP Restricts SFV Infection in Human Cells through the PARP Domain
###end title 36
###begin p 37
###xml 73 78 <span type="species:ncbi:9606">human</span>
###xml 83 86 <span type="species:ncbi:10116">rat</span>
(A) Western analysis with anti-HA antibody shows expression of HA-tagged human and rat ZAP isoforms in stably expressing HeLa cell lines. Equal amounts of protein were loaded in each lane.
###end p 37
###begin p 38
###xml 4 7 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
###xml 168 171 <span type="species:ncbi:10116">rat</span>
###xml 304 307 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
(B) SFV infection was strongly inhibited (7-fold) in HeLa cells stably expressing ZAP(L), but only weakly restricted (2-fold) in HeLa cells stably expressing ZAP(S) or rat NZAP. Cells were challenged with four 3-fold serial dilutions of virus in quadruplicate and infectivity was determined by measuring SFV-driven beta-galactosidase activity as relative light units using a luminescent substrate. The data are plotted as the means +/- standard deviation on a log scale.
###end p 38
###begin p 39
###xml 4 7 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 235 238 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(C) HIV infection was not attenuated in HeLA cells stably expressing the ZAP isoforms. HeLa cells stably expressing the ZAP isoforms were challenged by five 3-fold serial dilutions of virus, and infectivity was determined by measuring HIV-driven luciferase activity (relative light units). The data are plotted as the means +/- standard deviations on a log scale.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 109 115 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP(L)</italic>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b011">11</xref>
###xml 991 1002 991 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Togaviridae</italic>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b014">14</xref>
###xml 1014 1016 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b015">15</xref>
###xml 1034 1046 1034 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Retroviridae</italic>
###xml 281 286 <span type="species:ncbi:9606">human</span>
###xml 325 328 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
###xml 333 336 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 350 355 <span type="species:ncbi:9606">human</span>
###xml 400 405 <span type="species:ncbi:9606">human</span>
###xml 422 425 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
###xml 435 438 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 535 538 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
###xml 590 593 <span type="species:ncbi:10116">rat</span>
###xml 621 627 <span type="species:ncbi:10090">murine</span>
###xml 640 643 <span type="species:ncbi:11786">MLV</span>
###xml 708 711 <span type="species:ncbi:11786">MLV</span>
###xml 785 790 <span type="species:ncbi:9606">human</span>
###xml 838 841 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
Our evolutionary analyses of primate ZAP(L) reveals that the C-terminal PARP-like domain encoded only by the ZAP(L) isoform is in fact the only domain that is under recurrent positive selection. Based on this insight from our evolutionary analysis, we tested the abilities of both human ZAP(L) and ZAP(S) isoforms to inhibit SFV and HIV infection in human cells. Our results clearly demonstrate that human ZAP can inhibit SFV, but not HIV, and that the presence of the PARP domain significantly enhances the ability of ZAP to suppress SFV infection. While previous work also implicated the rat ZAP as an inhibitor of the murine retrovirus, MLV, in rodent cells [11], we do not observe such an effect against MLV infection (unpublished data) at the level of ZAP expressed in our stable human cell lines, even though we do see an effect on SFV infection in the same cell lines. Therefore, we believe that the viral antagonist(s) that drove ZAP evolution in primates was likely a member of the Togaviridae family [14,15] rather than the Retroviridae family.
###end p 41
###begin p 42
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b012">12</xref>
###xml 122 130 122 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g003">Figure 3</xref>
###xml 109 112 <span type="species:ncbi:11786">MLV</span>
###xml 117 120 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The rZAP CCCH domain can be very specific in its RNA-binding and antiviral activity [12]. Our experiments on MLV and HIV (Figure 3) suggest that the RNA-binding specificities of rodent and primate ZAP are not significantly different. Our analyses cannot rule out the possibility that some subtle alteration of RNA-binding may have occurred during the course of mammalian evolution. However, the absence of positive selection in the CCCH domain unambiguously rules out an evolutionary conflict scenario in which the restrictive ability of ZAP was shaped by repeated episodes of selection for dramatic alterations in RNA-binding activity.
###end p 42
###begin p 43
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b019">19</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b026">26</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b028">28</xref>
###xml 490 499 490 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0040021-sg004">Figure S4</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b029">29</xref>
It is not yet clear what role a PARP-like domain could play in ZAP function. PARP function has been primarily characterized in the nucleus where it is believed that the addition of ADP-ribose moieties to chromatin proteins results in their looser association with DNA, thereby allowing greater access to transcription and DNA repair machineries [19,26-28]. A similar mechanism of protein modification by ZAP's PARP domain could be imagined to disrupt binding by viral RNA-binding proteins (Figure S4). However, the ZAP PARP-like domain lacks what is believed to be an essential catalytic glutamic acid (position 988 in PARP-1) and therefore may not be catalytically active as a canonical PARP [29], although its NAD+ binding site is conserved.
###end p 43
###begin p 44
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b030">30</xref>
###xml 686 702 686 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">increase binding</italic>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b031">31</xref>
###xml 961 977 961 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">decrease binding</italic>
###xml 1328 1330 1328 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b032">32</xref>
###xml 1331 1333 1331 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b033">33</xref>
###xml 1355 1360 <span type="species:ncbi:9606">human</span>
While the mechanism by which the PARP-like domain mediates its antiviral effect is unknown, we can still address why the PARP-like domain has been evolving under positive selection. Using the model for antagonistic host-pathogen interactions, there are several possible scenarios for the adaptive evolution of the PARP-like domain in ZAP: either the PARP domain evolves towards recognizing the virus, or it evolves away from being recognized by the virus. In the first scenario, the PARP-like domain may increase ZAP's affinity for viral mRNA binding proteins (analogous to APOBEC3G associating with nucleocapsid [30]), in which case the PARP-like domain is under selective pressure to increase binding to viral proteins. The alternate possibility is that viruses may encode specific antagonists to bind ZAP's PARP domain and sequester or degrade ZAP (analogous to Vif degradation of APOBEC3G [31]), in which case the selective pressure on ZAP PARP would be to decrease binding with viral antagonists. We favor the latter possibility because the residues that show a recurrent signature of positive selection also fall proximal to the NAD+ binding sites, which may be essential for any PARP-like function. Given the recent re-emergence of alphavirus epidemics in Africa and Asia and the reports of alphavirus disease in Europe [32,33], our discovery that human ZAP encodes a potent anti-alphaviral activity that depends on the PARP domain may guide future strategies for therapeutic drug design to treat alphavirus-related disease.
###end p 44
###begin title 45
Materials and Methods
###end title 45
###begin title 46
RT-PCR and sequencing.
###end title 46
###begin p 47
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 139 147 139 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g002">Figure 2</xref>
###xml 756 764 756 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP (L),</italic>
###xml 843 846 843 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 246 252 <span type="species:ncbi:9581">gibbon</span>
###xml 752 755 <span type="species:ncbi:10116">rat</span>
Human, chimp, and rhesus ZAP sequences were obtained from the respective genome projects. We amplified ZAP genes from additional primates (Figure 2A) by RT- PCR using RNA isolated from individual cell lines (obtained from Coriell and E. Eichler [gibbon]). RT-PCR was done in two overlapping fragments using the Invitrogen One-Step RT-PCR with Platinum Taq kit (Invitrogen). To amplify the 5' half of the gene, we used the following primers to generate a 1.4 kb fragment: Forward-5' ATGGCGGACCCGGAGGTG, Reverse-5' CTCGGGAAGCAGGTCCAGCATCC. The 3' half of the gene was amplified as a 1.4 kb fragment with the following primers: Forward-5' AATGCTGATGGAGTGGCCACAG, Reverse-5' GACAACTAACTAATCACGCAGGCTTTGTC. To demonstrate the existence of a PARP-containing rat ZAP (L), the following primers were used to generate a fragment spanning exons 7-13 of ZAP: Forward-5' TCTGACTCCTACCCCATCCGA, Reverse-5' GCAACCTTTCTCTTTCTCTGATTCCAC. All sequencing was done using ABI BigDye version 3.0.
###end p 47
###begin title 48
Nucleotide sequence accession numbers.
###end title 48
###begin p 49
Sequences obtained in this study were deposited in Genbank and assigned accession numbers EF494425-EF494434.
###end p 49
###begin title 50
Expression panels.
###end title 50
###begin p 51
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
To detect ZAP expression in different human tissues, we used human cDNA panels in which 5 ng of first-strand cDNA from various tissues were preloaded (Primgen) and performed PCR using primers specific to either the ZAP(S) or ZAP(L) isoform.
###end p 51
###begin title 52
Evolutionary analyses.
###end title 52
###begin p 53
###xml 19 21 19 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b034">34</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b035">35</xref>
###xml 999 1001 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b021">21</xref>
###xml 1198 1200 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b036">36</xref>
We used Clustal_X [34] to generate a multiple alignment for ZAP from all primate species sequenced. Maximum likelihood analysis was performed with codeml in the PAML 3.14.1 software package [35]. To detect selection, multiple alignments were fitted to the NSsites models that disallow positive selection (M1, M7, M8a) or to models that permit positive selection (M2, M8, M8b, respectively) assuming the f61 model of codon frequencies. Simulations were run with multiple starting values for dN/dS. Likelihood ratio tests were performed to assess whether permitting codons to evolve under positive selection gives a significantly better fit to the data. To identify specific codons that are evolving under recurrent positive selection, we used the NSsites model from codeml in the PAML 3.14.1 software. To confirm the sites identified by the codeml approach, we also implemented the random effects method (REL) from the online DataMonkey package, with a Bayes significance factor of 50 as the cutoff [21]. The REL approach differs from NSsites in that it allows the synonymous substitution rate to vary among codons. Our pairwise sliding window analyses were performed using the K-estimator program [36], with a 300 bp window and a 50 bp slide.
###end p 53
###begin title 54
Expression constructs.
###end title 54
###begin p 55
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 395 398 <span type="species:ncbi:10116">rat</span>
###xml 797 800 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
N-terminal hemagglutinin (HA)-tagged human ZAP(L) and ZAP(S) were cloned by reverse transcription (RT)-PCR from RNA isolated from 293T cells using the HA-specific 5' primer, 5'-CAGGCGAATTCGCCACCATGTATCCATACGATGTTCCAGATTACGCTGCGGACCCGGAGGTGTGC-3', and isoform-specific 3' primers as follows: HA-ZAP(L)-5' TTCAGGATATCCTAACTAATCACGCAGGC-3' and HA-ZAP(S)-5'-TTCAGGATATCCTATCTCTTCATCTGCTGCAC-3'. The rat N-terminal HA-tagged NZAP was cloned by RT-PCR from RNA isolated from Rat2 fibroblasts using the HA-specific 5' primer, 5'-CAGGCGAATTCGCCACCATGTATCCATACGATGTTCCAGATTACGCTGCAGATCCCGGGGTA-3' and the 3' primer, 5'-TTCAGGATATCTCAGTGAAGGAAGCGGTCTCT-3'. Each gene was transferred into the same mammalian expression vector (pcDNA4; Invitrogen) which drives gene expression under the cytomegalovirus IE94 (CMV) promoter. All constructs were confirmed by sequencing.
###end p 55
###begin title 56
Cell culture.
###end title 56
###begin p 57
###xml 139 140 133 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 83 89 <span type="species:ncbi:9913">bovine</span>
HeLa cells were cultured in Dulbecco's modified Eagle medium (DMEM) with 10% fetal bovine serum and were maintained at 37 degreesC in 5% CO2. To create stably expressing cell lines, the ZAP constructs were individually transfected into HeLa cells using Fugene6 Reagent (Roche) and stably expressing lines were selected and maintained with Zeocin (0.1 mg/ml). The expression levels for clonally derived lines were checked by Western analysis using an HA-specific antibody (HA.11; Covance) and the highest expressing lines were chosen for the infectivity assays.
###end p 57
###begin title 58
Transient cotransfection, luciferase assay, and Western blot analysis.
###end title 58
###begin p 59
Transient co-transfections were performed using the Mirius TransIT-LTR Transfection reagent according to the manufacturer's recommendations. All cells were transfected with a total of 300 ng DNA comprising 100 ng LlucSN plus empty pcDNA4 vector (No ZAP), HA- ZAP expression plasmid (HA-hZAPL, HA-hZAPS, or HA-rNZAP), as indicated, and the total DNA transfected was equalized with empty pcDNA4 vector. After 48 h, the cells from triplicate tranfections were lysed using 150 mul of Cell Culture Lysis reagent (Promega). To quantify the luciferase activity, 20 mul of lysate was analyzed with a Luciferase Assay kit (Promega) and luciferase activity (light intensity) was measured with a luminometer.
###end p 59
###begin p 60
###xml 820 831 <span type="species:ncbi:3704">horseradish</span>
###xml 860 864 <span type="species:ncbi:9925">goat</span>
###xml 870 875 <span type="species:ncbi:10090">mouse</span>
###xml 972 978 <span type="species:ncbi:9986">rabbit</span>
###xml 1059 1065 <span type="species:ncbi:9793">donkey</span>
###xml 1071 1077 <span type="species:ncbi:9986">rabbit</span>
For Western blot analysis, 293T cells were plated and transfected as described above using different amounts of transfected HA-huZAP(L) or HA-huZAP(S), with the total amount of transfected DNA equalized using empty pCDNA4. After 48 h, the lysates from these cells were harvested with NP-40-doc buffer (20 mM Tris [pH 8.0], 120 mM NaCl, 1 mM EDTA, 1% NP-40, 0.2% Na-deoxycholate, and protease inhibitors [Roche complete cocktail tablets]), and incubated on ice for 5 min and then frozen at -20 degreesC. Lysates were resuspended in SDS loading buffer, boiled for 5 min, and then loaded and run on a 12% NuPAGE Novex Bis-Tris Gel and transferred to nitrocellulose membrane (Pierce). For HA-tagged ZAP protein detection, membranes were probed with a HA-specific antibody (HA.11; Covance) at a 1:2,000 dilution, followed by horseradish peroxidase (HRP)-conjugated goat anti-mouse secondary antibody (Amersham Biosciences) at a 1:3,000 dilution. For Actin protein detection, a rabbit anti-Actin Ab (Sigma) was used at 1:10,000 dilution, followed by HRP-conjugated donkey anti-rabbit secondary antibody (Amersham Biosciences) at 1:3,000. Detection was performed with the ECL Plus Reagent (Amersham Biosciences).
###end p 60
###begin title 61
Virus stocks.
###end title 61
###begin p 62
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b025">25</xref>
###xml 220 222 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b037">37</xref>
###xml 0 3 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
###xml 155 158 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 179 182 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
SFV virus was made using the DNA-based Semliki Forest Virus vectors (pSMARTlacZ and pSCAHelper), which were a kind gift from Dr. Rod Bremner [25]. To make HIV virus stock we used HIV-luc2Deltaenv pseudotyped with VSV-G [37]. To make the virus stocks, the constructs were transiently transfected into 293T cells with FuGene6 Reagent (Roche). Virus released into the cell culture supernatant by 48 h was harvested, clarified by centrifugation, and stored at -80 degreesC.
###end p 62
###begin title 63
Single-cycle infectivity assays.
###end title 63
###begin p 64
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0040021-b025">25</xref>
###xml 114 115 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 0 3 <span type="species:ncbi:10271?0.09544787077826726|species:ncbi:11642?0.023494860499265784|species:ncbi:11096?0.011747430249632892">SFV</span>
SFV infections were performed as previously described [25]. Briefly, cells were plated in 96 well plates at 2 x 104 cells per well the day before infection. Virus was thawed and treated with chymotrypsin to generate active virus and HeLa cell lines (normal and stably expressing ZAP isoforms) were challenged with 3-fold serial dilutions of active virus. After 24 h, the cells were lysed and the beta-galactosidase activity was measured using Galacton (Tropix) as a substrate with 1-s measurements using a luminometer (Thermo Fluoroskin Ascent, Thermo).
###end p 64
###begin p 65
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 8 11 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 194 197 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
For the HIV infections, cells (normal or stably expressing ZAP isoforms) were plated in 96-well plates at 2 x 104 cells per well and after 24 h were challenged for 48 h with serial dilutions of HIV virus. After 48 h, the cells were lysed using the Cell Culture Lysis reagent (Promega). To quantify the luciferase activity, the lysate was analyzed with a Luciferase Assay kit (Promega) and luciferase activity (light intensity) was measured with a luminometer.
###end p 65
###begin title 66
Supporting Information
###end title 66
###begin title 67
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZAP</italic>
Sliding Window dN/dS Analysis of Primate ZAP Genes
###end title 67
###begin p 68
###xml 154 159 <span type="species:ncbi:9606">human</span>
###xml 167 179 <span type="species:ncbi:9538">patas monkey</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 255 268 <span type="species:ncbi:9511">spider monkey</span>
Sliding window (300 bp window, 50 bp slide) analyses of dN and dS were performed, and 3 representative pairs of primate ZAP genes are shown: (A) HOM-OWM (human versus patas monkey), (B) HOM-NWM (human versus woolly monkey), and (C) OWM-NWM (rhesus versus spider monkey). For each pairwise comparison, dN/dS (thick line) and dS (thin line) are plotted against the length of the protein with the schematic of the protein shown at the bottom. A dotted line represents where dN/dS = 1, consistent with the neutral expectation.
###end p 68
###begin p 69
(270 KB PDF)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin title 71
Multiple Sequence Alignment of Orthologous ZAP N-Terminal Domains
###end title 71
###begin p 72
An alignment of the first 230 amino acids of ZAP, corresponding to the CCCH zinc finger motifs, from 14 primates and six non-primate mammals. Residues are highlighted in black or gray to indicate complete conservation or high conservation, respectively. The putative NLS is indicated between residues 69 and 76 and the four CCCH fingers are shown below the alignment.
###end p 72
###begin p 73
(483 KB PDF)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin title 75
ZAP Paralogs in Vertebrates
###end title 75
###begin p 76
(A) There are at least four other proteins that share common structural features with ZAP. ZRP2, PARP12, and ZAP are located on 7q34; TiPARP is on 3q25; and PARP11 is on 12p13. Only ZAP is evolving under positive selection (red arrow).
###end p 76
###begin p 77
(B) ZRP2 (NP_542391) is a predicted 300 amino acid protein that contains the four CCCH type zinc fingers found in ZAP. PARP12 and ZAP share the CCCH fingers, the TPH (including 1 CCCH finger), WWE, and PARP-like domain. PARP11 and TiPARP lack the CCCH domain but both contain the WWE and PARP-like domain.
###end p 77
###begin p 78
(221 KB PDF)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin title 80
A Hypothetical Model for How ZAP PARP-Like Activity Might Enhance its Antiviral Function
###end title 80
###begin p 81
(A) In the nucleus, PARP adds poly(ADP-ribose) (PAR) moeities to chromatin proteins, thus loosening their association with DNA and opening the chromatin structure, which allows greater access to transcription and DNA repair machineries. This opening of the chromatin structure is reversed by PARG, a glycohydrolase that mediates the breakdown of PAR.
###end p 81
###begin p 82
(B) Our model proposes that ZAP restricts viral replication by adding PAR moieties to proteins associated with viral mRNAs in the cytoplasm, thus weakening their interaction and exposing the mRNA to exosomal degradation. Although PAR moeities are shown here, even addition of Mono (ADP-ribose) could mediate the same effects. It is presently unclear whether ZAP's PARP domain possesses such catalytic activity, since it is missing one of the critical catalytic residues previously thought to be essential for PARP activity.
###end p 82
###begin p 83
(708 KB PDF)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
###xml 123 131 123 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0040021-g004">Figure 4</xref>
###xml 138 144 <span type="species:ncbi:9581">gibbon</span>
###xml 289 294 <span type="species:ncbi:69235">Molly</span>
We are grateful to Lily Wu for helping with the isolation of primate RNAs from cell lines and for the Western blot data in Figure 4A. The gibbon cell line was a kind gift from the Eichler lab. We thank Danielle Vermaak, Sara Sawyer, Eric Smith, Katie Peichel, Shari Kaiser, Nels Elde, and Molly OhAinle for their comments on the manuscript, and members of the Malik and Emerman labs for helpful discussions.
###end p 85
###begin title 86
Abbreviations
###end title 86
###begin p 87
apolipoprotein B editing complex-like protein 3G
###end p 87
###begin p 88
number of non-synonymous substitutions per site
###end p 88
###begin p 89
number of synonymous substitutions per site
###end p 89
###begin p 90
poly(ADP-ribose) polymerase
###end p 90
###begin p 91
tripartite motif protein 5 alpha
###end p 91
###begin p 92
zinc-finger antiviral protein
###end p 92
###begin title 93
References
###end title 93
###begin article-title 94
Intrinsic immunity: A front-line defense against viral attack
###end article-title 94
###begin article-title 95
Retrovirus restriction factors
###end article-title 95
###begin article-title 96
Genetic control of retrovirus susceptibility in mammalian cells
###end article-title 96
###begin article-title 97
Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain
###end article-title 97
###begin article-title 98
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G
###end article-title 98
###begin article-title 99
Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H
###end article-title 99
###begin article-title 100
###xml 55 61 <span type="species:ncbi:9606">humans</span>
###xml 66 77 <span type="species:ncbi:9598">chimpanzees</span>
A scan for positively selected genes in the genomes of humans and chimpanzees
###end article-title 100
###begin article-title 101
Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases
###end article-title 101
###begin article-title 102
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lv1</italic>
###xml 37 43 <span type="species:ncbi:9913">cattle</span>
Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals
###end article-title 102
###begin article-title 103
Molecular phylogeny of Fv1
###end article-title 103
###begin article-title 104
Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein
###end article-title 104
###begin article-title 105
The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs
###end article-title 105
###begin article-title 106
The zinc-finger antiviral protein recruits the RNA processing exosome to degrade the target mRNA
###end article-title 106
###begin article-title 107
Expression of the zinc-finger antiviral protein inhibits alphavirus replication
###end article-title 107
###begin article-title 108
Identification and characterization of interferon-induced proteins that inhibit alphavirus replication
###end article-title 108
###begin article-title 109
Inhibition of filovirus replication by the zinc finger antiviral protein
###end article-title 109
###begin article-title 110
The WWE domain: A common interaction module in protein ubiquitination and ADP ribosylation
###end article-title 110
###begin article-title 111
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIPARP</italic>
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
Identification and characterization of human TIPARP gene within the CCNL amplicon at human chromosome 3q25.31
###end article-title 111
###begin article-title 112
The PARP superfamily
###end article-title 112
###begin article-title 113
PAML: A program package for phylogenetic analysis by maximum likelihood
###end article-title 113
###begin article-title 114
Datamonkey: Rapid detection of selective pressure on individual sites of codon alignments
###end article-title 114
###begin article-title 115
CDD: A conserved domain database for interactive domain family analysis
###end article-title 115
###begin article-title 116
###xml 71 78 <span type="species:ncbi:9031">chicken</span>
Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken
###end article-title 116
###begin article-title 117
Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling
###end article-title 117
###begin article-title 118
Rapid, high level protein production using DNA-based Semliki Forest virus vectors
###end article-title 118
###begin article-title 119
###xml 61 71 61 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 61 71 <span type="species:ncbi:7227">Drosophila</span>
Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci
###end article-title 119
###begin article-title 120
Regulation of chromatin structure and gene activity by poly(ADP-ribose) polymerases
###end article-title 120
###begin article-title 121
Poly(ADP-ribosyl)ation of polynucleosomes causes relaxation of chromatin structure
###end article-title 121
###begin article-title 122
###xml 29 34 <span type="species:ncbi:9606">human</span>
Role of glutamic acid 988 of human poly-ADP-ribose polymerase in polymer formation. Evidence for active site similarities to the ADP-ribosylating toxins
###end article-title 122
###begin article-title 123
###xml 80 85 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein
###end article-title 123
###begin article-title 124
###xml 80 85 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
###end article-title 124
###begin article-title 125
Infectious diseases. Massive outbreak draws fresh attention to little-known virus
###end article-title 125
###begin article-title 126
Epidemiology. Tropical disease follows mosquitoes to Europe
###end article-title 126
###begin article-title 127
The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools
###end article-title 127
###begin article-title 128
Bayes empirical bayes inference of amino acid sites under positive selection
###end article-title 128
###begin article-title 129
K-Estimator: Calculation of the number of nucleotide substitutions per site and the confidence intervals
###end article-title 129
###begin article-title 130
###xml 31 34 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The cell cycle independence of HIV infections is not determined by known karyophilic viral elements
###end article-title 130
###begin p 131
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. JAK, ME, and HSM conceived and designed the experiments, performed the experiments, analyzed the data, and wrote the paper. ME contributed reagents/materials/analysis tools.
###end p 131
###begin p 132
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This work was initiated using funds from by amfAR grant 106622-38-RGHF and a Searle Scholar Award to HSM, and National Institutes of Health (NIH) grant R37 AI30937 to ME. JAK was supported by a Viral Oncology Training Grant NIH T32-CA09229 and by a pilot grant from the Puget Sound Partners for Global Health to HSM.
###end p 132
###begin p 133
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 133

